0 Bewertungen

ID

31177

Beschreibung

Study ID: 104505 Clinical Study ID: BEX104505 Study Title: Phase II Study of Iodine 131 Anti B1 Antibody for 1st or 2nd Relapsed Indolent B-Cell Lymphomas or B-Cell Lymphomas That Have Transformed to a More Aggressive Histology Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00950755 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: tositumomab Trade Name: Bexxar Study Indication: Lymphoma, Non-Hodgkin This form is to be completed every 6 months once the patient has entered long-term follow-up.

Stichworte

  1. 25.07.18 25.07.18 -
Rechteinhaber

see clinicaltrials.gov

Hochgeladen am

25. Juli 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :


    Keine Kommentare

    Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

    Iodine 131 B1 Antibody for B-Cell Lymphomas NCT00950755

    Long-Term Follow-Up for Survival & Disease Status

    Default Itemgroup
    Beschreibung

    Default Itemgroup

    Site number
    Beschreibung

    Site number

    Datentyp

    text

    Alias
    UMLS CUI [1,1]
    C0018704
    UMLS CUI [1,2]
    C0600091
    Patient number
    Beschreibung

    Patient number

    Datentyp

    text

    Alias
    UMLS CUI [1]
    C1830427
    Patient initials
    Beschreibung

    Patient initials

    Datentyp

    text

    Alias
    UMLS CUI [1]
    C2986440
    Patient status
    Beschreibung

    Patient status

    Datentyp

    text

    Alias
    UMLS CUI [1]
    C0449437
    Date last known alive
    Beschreibung

    Date last known alive

    Datentyp

    date

    Alias
    UMLS CUI [1,1]
    C3274947
    UMLS CUI [1,2]
    C0011008
    Date of last contact
    Beschreibung

    Date of last contact

    Datentyp

    date

    Alias
    UMLS CUI [1]
    C0805839
    How contact was made
    Beschreibung

    Contact

    Datentyp

    text

    Alias
    UMLS CUI [1]
    C2051442
    Does the patient have an ongoing response to Iodine I 131 Tositumomab?
    Beschreibung

    Iodine I 131 Tositumomab

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0768182
    Additional therapy for NHL since the last LTFU
    Beschreibung

    Additional therapy for NHL since the last LTFU

    Alias
    UMLS CUI-1
    C0024305
    UMLS CUI-2
    C1706712
    Has any additional therapy for NHL been administered? (If yes, specify therapy and start dates in comment section below)
    Beschreibung

    additional therapy for NHL

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0024305
    UMLS CUI [1,2]
    C1706712
    Myelodysplasia
    Beschreibung

    Myelodysplasia

    Alias
    UMLS CUI-1
    C0026985
    Has the patient had a documented (bone marrow biopsy) new diagnosis of myelodysplasia?
    Beschreibung

    Myelodysplasia diagnosis

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0026985
    UMLS CUI [1,2]
    C0011900
    If yes, date of diagnosis
    Beschreibung

    Myelodysplasia Date of diagnosis

    Datentyp

    date

    Alias
    UMLS CUI [1,1]
    C0026985
    UMLS CUI [1,2]
    C2316983
    Another malignancy
    Beschreibung

    Another malignancy

    Alias
    UMLS CUI-1
    C0006826
    Has the patient had a new diagnosis of a secondary malignancy? (If yes, please specify type of malignancy)
    Beschreibung

    Malignancy Diagnosis

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0006826
    UMLS CUI [1,2]
    C0011900
    if yes, date of diagnosis
    Beschreibung

    Malignancy, Date of Diagnosis

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0006826
    UMLS CUI [1,2]
    C2316983
    Thyroid medication
    Beschreibung

    Thyroid medication

    Alias
    UMLS CUI-1
    C0040128
    UMLS CUI-2
    C0013227
    Is the patient taking thyroid medication?
    Beschreibung

    Thyroid medication

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0040128
    UMLS CUI [1,2]
    C0013227
    If yes, drug name
    Beschreibung

    Thyroid medication; drug name

    Datentyp

    text

    Alias
    UMLS CUI [1,1]
    C0040128
    UMLS CUI [1,2]
    C0013227
    UMLS CUI [1,3]
    C2360065
    Start Date
    Beschreibung

    Thyroid medication; Start Date

    Datentyp

    date

    Alias
    UMLS CUI [1,1]
    C0040128
    UMLS CUI [1,2]
    C0013227
    UMLS CUI [1,3]
    C0808070
    Comments
    Beschreibung

    Comments

    Alias
    UMLS CUI-1
    C0947611
    Comments
    Beschreibung

    Comments

    Datentyp

    text

    Alias
    UMLS CUI [1]
    C0947611

    Ähnliche Modelle

    Long-Term Follow-Up for Survival & Disease Status

    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datentyp
    Alias
    Site number
    Item
    Site number
    text
    C0018704 (UMLS CUI [1,1])
    C0600091 (UMLS CUI [1,2])
    Patient number
    Item
    Patient number
    text
    C1830427 (UMLS CUI [1])
    Patient initials
    Item
    Patient initials
    text
    C2986440 (UMLS CUI [1])
    Item
    Patient status
    text
    C0449437 (UMLS CUI [1])
    Code List
    Patient status
    CL Item
    Alive (1)
    CL Item
    Dead (complete "Notification of Patient Death" Form) (2)
    CL Item
    Lost to follow-up (3)
    Date last known alive
    Item
    Date last known alive
    date
    C3274947 (UMLS CUI [1,1])
    C0011008 (UMLS CUI [1,2])
    Date of last contact
    Item
    Date of last contact
    date
    C0805839 (UMLS CUI [1])
    Item
    How contact was made
    text
    C2051442 (UMLS CUI [1])
    Code List
    How contact was made
    CL Item
    Tumor registry (1)
    CL Item
    Contact with patient (2)
    CL Item
    Contact with MD (3)
    CL Item
    Other (4)
    CL Item
    Other (4)
    Iodine I 131 Tositumomab
    Item
    Does the patient have an ongoing response to Iodine I 131 Tositumomab?
    boolean
    C0768182 (UMLS CUI [1])
    Item Group
    Additional therapy for NHL since the last LTFU
    C0024305 (UMLS CUI-1)
    C1706712 (UMLS CUI-2)
    additional therapy for NHL
    Item
    Has any additional therapy for NHL been administered? (If yes, specify therapy and start dates in comment section below)
    boolean
    C0024305 (UMLS CUI [1,1])
    C1706712 (UMLS CUI [1,2])
    Item Group
    Myelodysplasia
    C0026985 (UMLS CUI-1)
    Myelodysplasia diagnosis
    Item
    Has the patient had a documented (bone marrow biopsy) new diagnosis of myelodysplasia?
    boolean
    C0026985 (UMLS CUI [1,1])
    C0011900 (UMLS CUI [1,2])
    Myelodysplasia Date of diagnosis
    Item
    If yes, date of diagnosis
    date
    C0026985 (UMLS CUI [1,1])
    C2316983 (UMLS CUI [1,2])
    Item Group
    Another malignancy
    C0006826 (UMLS CUI-1)
    Malignancy Diagnosis
    Item
    Has the patient had a new diagnosis of a secondary malignancy? (If yes, please specify type of malignancy)
    boolean
    C0006826 (UMLS CUI [1,1])
    C0011900 (UMLS CUI [1,2])
    Malignancy, Date of Diagnosis
    Item
    if yes, date of diagnosis
    boolean
    C0006826 (UMLS CUI [1,1])
    C2316983 (UMLS CUI [1,2])
    Item Group
    Thyroid medication
    C0040128 (UMLS CUI-1)
    C0013227 (UMLS CUI-2)
    Thyroid medication
    Item
    Is the patient taking thyroid medication?
    boolean
    C0040128 (UMLS CUI [1,1])
    C0013227 (UMLS CUI [1,2])
    Thyroid medication; drug name
    Item
    If yes, drug name
    text
    C0040128 (UMLS CUI [1,1])
    C0013227 (UMLS CUI [1,2])
    C2360065 (UMLS CUI [1,3])
    Thyroid medication; Start Date
    Item
    Start Date
    date
    C0040128 (UMLS CUI [1,1])
    C0013227 (UMLS CUI [1,2])
    C0808070 (UMLS CUI [1,3])
    Item Group
    Comments
    C0947611 (UMLS CUI-1)
    Comments
    Item
    Comments
    text
    C0947611 (UMLS CUI [1])

    Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

    Zum Video